The Asia Pacific diabetes care devices market is expected to reach US$ 8,880.7 Mn in 2027 from US$ 5,011.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027.
The growth of the diabetes care devices market is primarily attributed to the rapid technological advancements in diabetes care devices and increasing rate of obesity. However, high cost of diabetes care devices and increasing prevalence of type 2 diabetes are likely to pose a negative impact on the market growth. On the other hand, growing medical tourism in developing countries is likely to have a positive impact on the growth of the Asia Pacific diabetes care devices market in the coming years.
The advancement in the field of the healthcare industry is driving to the players for more research and developments for the diabetes care devices for the administration purpose required during various medical conditions. The pen needles used in various injection pens have evolved gradually in terms of material, performance, dimensions and safety factors such as sterility and safety packaging. Various manufacturers are coming up with innovative products to sustain in the highly fragmented diabetes care devices market, in the region. Moreover, the easy regulatory approvals in the Asian countries has led to mid-sized companies enter the market and compete with the local and established players. For instance, in May 2018, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of disposable syringes introduced "Dispovan" insulin pen needle which is the first made-in-India disposable pen needle that is technologically efficient and affordable than that of the currently available products in the market. Development of pen needles with precise lubrication to reduce the pain sensation has been another focus of manufacturers during the research. Thus, owing to the above mentioned factors the market for diabetes care devices anticipated to grow rapidly in the forecast period, in the region.
In 2018, the glucose monitoring devices segment held a largest market share of 54.0% of the diabetes care devices market, by product. The glucose monitoring devices is expected to dominate its market share in 2027 owing to the rise in the prevalence of the type 2 diabetes in the region. The testing strips segment among the glucose monitoring devices is anticipated to witness the fastest growth rate of 7.6% during the forecast period, 2019 to 2027 owing to the enormous usages in the glucose monitoring devices.
Homecare held a largest market share of 59.8% of the diabetes care devices market, by end user. This segment is also expected to dominate the market in 2027 owing to the rise in the demand for the glucose monitoring devices and insulin delivery devices. Increasing prevalence of diabetes, the ease of use, availability, and accessibility of insulin delivery devices has also increased the adoption of self-administration among patients is anticipated to grow at a steady rate during the forecast period. Also the homecare segment is also expected to grow at the fastest growth rate of 6.9% during the forecast period, 2019 to 2027.
Some of the major primary and secondary sources for diabetes care devices included in the report are, China Initiative for Diabetes Excellence (CIDE), Centers for Diabetes and Endocrinology (CDE), Public Health England (PHE), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), International Diabetes Federation (IDF) and others.
TABLE OF CONTENTS
1. Introduction 17
1.1 Scope Of The Study 17
1.2 Publisher Research Report Guidance 17
2. Asia Pacific Diabetes Care Devices Market - Key Takeaways 19
3. Asia Pacific Diabetes Care Devices Market - Market Landscape 23
3.1 Overview 23
3.2 Market Segmentation 24
 3.2.1 Asia Pacific Diabetes Care Devices Market - By Product 25
 3.2.2 Asia Pacific Diabetes Care Devices Market - By End User 25
 3.2.3 Asia Pacific Diabetes Care Devices Market - By Country 25
3.3 PEST Analysis 27
4. Asia Pacific Diabetes Care Devices Market - Key Market Dynamics 31
4.1 Key Market Drivers 31
 4.1.1 Rapid Technological Advancements in Diabetes Care Devices 31
 4.1.2 Increasing Rate of Obesity 31
4.2 Key Market Restraints 32
 4.2.1 High Cost of Diabetes Care Devices 32
 4.2.2 Increasing prevalence of Type 2 Diabetes 33
4.3 Key Market Opportunities 34
 4.3.1 Growing Medical Tourism In Developing Countries 34
4.4 Future Trends 35
 4.4.1 Increasing Prevalence of Obesity Across The Region 35
4.5 Impact Analysis 36
5. Diabetes Care Devices Market - Asia Pacific Analysis 37
5.1 Asia Pacific Diabetes Care Devices Market Revenue Forecasts And Analysis 37
5.2 Market Positioning 38
5.3 Performance of Key Players 38
 5.3.1 Medtronic 38
 5.3.2 F. Hoffmann-La Roche Ltd. 39
6. Asia Pacific Diabetes Care Devices Market Analysis - By Product 40
6.1 Overview 40
6.2 Asia Pacific Diabetes Care Devices Market By Product, 2018 & 2027 (%) 40
6.3 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn) 41
 6.3.1 Asia Pacific Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 41
 6.3.2 Asia Pacific Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 42
6.4 Glucose Monitoring Devices Market 43
 6.4.1 Overview 43
 6.4.2 Asia Pacific Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn) 43
 6.4.3 Glucometers Market 44
 6.4.3.1 Overview 44
 6.4.3.2 Asia Pacific Glucometers Market Revenue and Forecast to 2027 (US$ Mn) 45
 6.4.4 Lancets Market 46
 6.4.4.1 Overview 46
 6.4.4.2 Asia Pacific Lancets Market Revenue and Forecast to 2027 (US$ Mn) 46
 6.4.5 Testing Strips Market 47
 6.4.5.1 Overview 47
 6.4.5.2 Asia Pacific Testing Strips Market Revenue and Forecast to 2027 (US$ Mn) 48
 6.4.6 Other Glucose Monitoring Devices Market 49
 6.4.6.1 Overview 49
 6.4.6.2 Asia Pacific Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn) 49
6.5 Insulin Delivery Devices Market 51
 6.5.1 Overview 51
 6.5.2 Asia Pacific Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn) 51
 6.5.3 Insulin Pens Market 53
 6.5.3.1 Overview 53
 6.5.3.2 Asia Pacific Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn) 53
 6.5.4 Insulin Syringes Market 55
 6.5.4.1 Overview 55
 6.5.4.2 Asia Pacific Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn) 55
 6.5.5 Insulin Pumps Market 57
 6.5.5.1 Overview 57
 6.5.5.2 Asia Pacific Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn) 57
 6.5.6 Other Insulin Delivery Devices Market 58
 6.5.6.1 Overview 58
 6.5.6.2 Asia Pacific Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn) 59
7. Asia Pacific Diabetes Care Devices Market Analysis - By End User 60
7.1 Overview 60
7.2 Asia Pacific Diabetes Care Devices Market, By End User, 2018 & 2027 (%) 60
7.3 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn) 61
7.4 Homecare Market 62
 7.4.1 Overview 62
 7.4.2 Asia Pacific Homecare Market Revenue and Forecasts to 2027 (US$ Mn) 62
7.5 Hospitals & Clinics Market 64
 7.5.1 Overview 64
 7.5.2 Asia Pacific Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn) 64
8. Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027 66
8.1 Overview 66
8.2 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027 (Us$ Mn) 68
8.3 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn) 69
 8.3.1 Asia Pacific Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 69
 8.3.2 Asia Pacific Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 70
8.4 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn) 71
8.5 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By Country (%) 71
8.6 China Diabetes Care Devices Market 72
 8.6.1 China Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 73
 8.6.2 China Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn) 74
 8.6.2.1 China Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 74
 8.6.2.2 China Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 75
 8.6.2.3 China Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn) 75
8.7 Japan Diabetes Care Devices Market 76
 8.7.1 Japan Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 76
 8.7.2 Japan Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn) 77
 8.7.2.1 Japan Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 78
 8.7.2.2 Japan Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 78
 8.7.3 Japan Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn) 79
8.8 India Diabetes Care Devices Market 80
 8.8.1 India Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 80
 8.8.2 India Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn) 81
 8.8.2.1 India Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 82
 8.8.2.2 India Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 82
 8.8.3 India Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn) 83
8.9 Australia Diabetes Care Devices Market 84
 8.9.1 Australia Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 84
 8.9.2 Australia Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn) 85
 8.9.2.1 Australia Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 86
 8.9.2.2 Australia Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 86
 8.9.3 Australia Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn) 87
8.10 South Korea Diabetes Care Devices Market 88
 8.10.1 South Korea Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 88
 8.10.2 South Korea Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn) 89
 8.10.2.1 South Korea Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 90
 8.10.2.2 South Korea Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 90
 8.10.3 South Korea Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn) 91
9. Diabetes Care Devices Market - Industry Landscape 92
9.1 Overview 92
9.2 Comparative Company Analysis 92
9.3 Growth Strategies Done By The Companies In The Market, (%) 94
9.4 Organic Developments 95
 9.4.1 Overview 95
9.5 Inorganic Developments 97
 9.5.1 Overview 97
10. Diabetes Care Devices Market-Key Company Profiles 98
 10.1 BD 98
 10.1.1 Key Facts 98
 10.1.2 Business Description 99
 10.1.3 Financial Overview 100
 10.1.4 Product Portfolio 100
 10.1.5 SWOT Analysis 101
 10.1.6 Key Developments 101
10.2 Novo Nordisk A/S 102
 10.2.1 Key Facts 102
 10.2.2 Business Description 102
 10.2.3 Financial Overview 103
 10.2.4 Product Portfolio 104
 10.2.5 SWOT Analysis 104
 10.2.6 Key Developments 105
10.3 B. Braun Melsungen AG 106
 10.3.1 Key Facts 106
 10.3.2 Business Description 106
 10.3.3 Financial Overview 107
 10.3.4 Product Portfolio 108
 10.3.5 SWOT Analysis 109
 10.3.6 Key Developments 109
10.4 Medtronic 110
 10.4.1 Key Facts 110
 10.4.2 Business Description 110
 10.4.3 Financial Information 111
 10.4.4 Product Portfolio 112
 10.4.5 SWOT Analysis 113
 10.4.6 Key Developments 114
10.5 Tandem Diabetes Care, Inc. 116
 10.5.1 Key Facts 116
 10.5.2 Business Description 116
 10.5.3 Financial Information 117
 10.5.4 Product Portfolio 117
 10.5.5 SWOT Analysis 118
 10.5.6 Key Developments 119
10.6 Insulet Corporation 121
 10.6.1 Key Facts 121
 10.6.2 Business Description 121
 10.6.3 Financial Information 122
 10.6.4 Product Portfolio 123
 10.6.5 SWOT Analysis 123
 10.6.6 Key Developments 124
10.7 Eli Lilly And Company 126
 10.7.1 Key Facts 126
 10.7.2 Business Description 126
 10.7.3 Financial Overview 127
 10.7.4 Product Portfolio 128
 10.7.5 SWOT Analysis 128
 10.7.6 Key Developments 129
10.8 Dexcom, Inc. 130
 10.8.1 Key Facts 130
 10.8.2 Business Description 130
 10.8.3 Financial Overview 131
 10.8.4 Product Portfolio 131
 10.8.5 SWOT Analysis 133
 10.8.6 Key Developments 134
10.9 Terumo Corporation 135
 10.9.1 Key Facts 135
 10.9.2 Business Description 135
 10.9.3 Financial Overview 136
 10.9.4 Product portfolio 137
 10.9.5 SWOT ANALYSIS 137
 10.9.6 KEY DEVELOPMENTS 138
10.10 F. Hoffmann-La Roche Ltd. 139
 10.10.1 Key Facts 139
 10.10.2 Business Description 139
 10.10.3 Financial Overview 140
 10.10.4 Product Portfolio 141
 10.10.5 SWOT Analysis 142
 10.10.6 Key Developments 143
11. Appendix 144
11.1 About Publisher 144
11.2 Glossary Of Terms 145
11.3 Methodology 148
 11.3.1 Coverage 150
 11.3.2 Secondary Research 150
 11.3.3 Primary Research 151
LIST OF TABLES
LIST OF FIGURES
The List of Companies
1. BD
2. Novo Nordisk A/S
3. B. Braun Melsungen AG
4. Insulet Corporation
5. Medtronic
6. Tandem Diabetes Care, Inc.
7. Eli Lilly and Company
8. Dexcom, Inc.
9. Terumo Corporation
10. F. Hoffman-LA Roche Ltd.